Patents by Inventor Nicole SCANGARELLA-OMAN

Nicole SCANGARELLA-OMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108620
    Abstract: The present invention relates to a novel treatment method for the treatment of an infection caused by Neisseria gonorrhoeae, comprising administering gepotidacin or a pharmaceutically acceptable salt thereof to a human in need thereof, in accordance with a treatment regimen as defined herein.
    Type: Application
    Filed: November 15, 2023
    Publication date: April 4, 2024
    Inventors: Nicole SCANGARELLA-OMAN, Etienne F. Dumont, Aline Bergesch Barth
  • Publication number: 20220257615
    Abstract: The present invention relates to methods for treating bacterial infections caused by or associated with Mycoplasma genitalium, which comprises administration of gepotidacin or pharmaceutically acceptable salts thereof, and doxycycline to a human in need thereof. Novel pharmaceutical combinations, compositions, resistance guided therapies and/or corresponding uses thereof are also disclosed.
    Type: Application
    Filed: July 3, 2020
    Publication date: August 18, 2022
    Inventor: Nicole SCANGARELLA-OMAN
  • Publication number: 20220184071
    Abstract: Disclosed are methods and compounds for use for treating urinary tract infection comprising administering gepotidacin or a pharmaceutically acceptable salt thereof, in a therapeutically effective amount in a human in need thereof, wherein the urinary tract infection is caused by one or more bacterium as defined herein.
    Type: Application
    Filed: April 3, 2019
    Publication date: June 16, 2022
    Inventors: David John PAYNE, Stephen RITTENHOUSE, Nicole SCANGARELLA-OMAN
  • Publication number: 20210308131
    Abstract: The present invention relates to a novel treatment method for the treatment of an infection caused by Neisseria gonorrhoeae, comprising administering gepotidacin or a pharmaceutically acceptable salt thereof to a human in need thereof, in accordance with a treatment regimen as defined herein.
    Type: Application
    Filed: April 1, 2021
    Publication date: October 7, 2021
    Inventors: Nicole SCANGARELLA-OMAN, Etienne F. Dumont, Aline Bergesch Barth